Literature DB >> 36200029

A case of hilar biliary cystadenoma with elevated IgG4 levels.

Zushun Chen1, Haiming Lu1, Jingxuan Xu1, Liang Ma1.   

Abstract

Cholangiocytic adenoma in the hilar bile duct is rare, and elevated IgG4 at the same time is extremely rare. This situation has not been reported in the literature. Nonetheless, the current case involved hilar biliary cystadenoma with elevated IgG4 levels. A 66-year-old man presented at this hospital with dark tea-colored urine. Preoperative imaging studies suggested hilar cholangiocarcinoma. This case demonstrates the difficulty of preoperative diagnosis of benign hilar lesions and the rarity of two combined benign lesions. A point of contention is whether this case should be treated with surgery or hormone therapy. 2022, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.

Entities:  

Keywords:  IgG4; biliary cystadenoma; hilar cholangiocarcinoma; immunoglobulin G4-related cholangitis; jaundice

Year:  2022        PMID: 36200029      PMCID: PMC9438001          DOI: 10.5582/irdr.2022.01076

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  11 in total

1.  Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012.

Authors:  Hirotaka Ohara; Kazuichi Okazaki; Hirohito Tsubouchi; Kazuo Inui; Shigeyuki Kawa; Terumi Kamisawa; Susumu Tazuma; Kazushige Uchida; Kenji Hirano; Hitoshi Yoshida; Takayoshi Nishino; Shigeru B H Ko; Nobumasa Mizuno; Hideaki Hamano; Atsushi Kanno; Kenji Notohara; Osamu Hasebe; Takahiro Nakazawa; Yasuni Nakanuma; Hajime Takikawa
Journal:  J Hepatobiliary Pancreat Sci       Date:  2012-09       Impact factor: 7.027

Review 2.  New Thoughts on Immunoglobulin G4-Related Sclerosing Cholangitis.

Authors:  Wouter L Smit; Emma L Culver; Roger W Chapman
Journal:  Clin Liver Dis       Date:  2015-10-06       Impact factor: 6.126

3.  IgG4 cholangiopathy: current concept, diagnosis, and pathogenesis.

Authors:  Kazuichi Okazaki; Kazushige Uchida; Masanori Koyabu; Hideaki Miyoshi; Tsukasa Ikeura; Makoto Takaoka
Journal:  J Hepatol       Date:  2014-04-24       Impact factor: 25.083

4.  Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.

Authors:  Abdul M Oseini; Roongruedee Chaiteerakij; Abdirashid M Shire; Amaar Ghazale; Joseph Kaiya; Catherine D Moser; Ileana Aderca; Teresa A Mettler; Terry M Therneau; Lizhi Zhang; Naoki Takahashi; Suresh T Chari; Lewis R Roberts
Journal:  Hepatology       Date:  2011-08-08       Impact factor: 17.425

5.  Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct.

Authors:  Yoh Zen; Takahiko Fujii; Keita Itatsu; Koichi Nakamura; Fumio Konishi; Shinji Masuda; Takeshi Mitsui; Yasuyuki Asada; Shouji Miura; Shiro Miyayama; Takeshi Uehara; Tsutomu Katsuyama; Tetsuo Ohta; Hiroshi Minato; Yasuni Nakanuma
Journal:  Mod Pathol       Date:  2006-06-02       Impact factor: 7.842

6.  Biliary cystadenoma and other complicated cystic lesions of the liver: diagnostic and therapeutic challenges.

Authors:  Anthony Y B Teoh; Simon S M Ng; K F Lee; Paul B S Lai
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

Review 7.  Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature.

Authors:  K G Ishak; G W Willis; S D Cummins; A A Bullock
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

8.  Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.

Authors:  Amaar Ghazale; Suresh T Chari; Lizhi Zhang; Thomas C Smyrk; Naoki Takahashi; Michael J Levy; Mark D Topazian; Jonathan E Clain; Randall K Pearson; Bret T Petersen; Santhi Swaroop Vege; Keith Lindor; Michael B Farnell
Journal:  Gastroenterology       Date:  2007-12-07       Impact factor: 22.682

Review 9.  Extrahepatic biliary cystadenomas and cystadenocarcinoma. Report of seven cases and review of the literature.

Authors:  W Davies; M Chow; D Nagorney
Journal:  Ann Surg       Date:  1995-11       Impact factor: 12.969

10.  Poor response of initial steroid therapy for IgG4-related sclerosing cholangitis with multiple organs affected.

Authors:  Wei Liu; Weijie Chen; Xiaodong He; Qiang Qu; Tao Hong; Binglu Li
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.